Recalls & Warnings February 20, 2013 Recall: Arthritis and Muscle Pain Supplement Contains Prescription Drugs On February 15, 2013, Reumofan Plus USA, LLC and Reumofan USA, LLC announced a recall of Reumofan Plus, a dietary supplement promoted for arthritis and muscle pain, because it was found to contain the active pharmaceutical ingredients methocarbamol, dexamethasone, and diclofenac
TB-500 (Thymosin Beta-4 fragment) and BPC-157 are often compared
Factor 2: Injection speed Reviews mentioning "slow injection over 30-45 seconds" report 28% less soreness than those describing "quick push in 5-10 seconds." The mechanism: slower injection allows tissue expansion and reduces mechanical trauma
Limitations and Research Status While preclinical data is extensive, large-scale human clinical trials are limited
Wnt signalling pathway
But BPC-157 may soon become easier to obtain through more reputable channels